Skip to main content

Ortivus AB (publ) quarterly report for the period January – June 2020

2020-08-21 08:30

Ortivus has successfully completed large deliveries to our British customers during the quarter

Highlights April – June 2020

  • Delivery of MobiMed to primary care in Region Jämtland Härjedalen
  • Hardware delivery completed to Northern Ireland Ambulance Service
  • Hardware delivery completed to South Western Ambulance Service
  • The next phase in the integration project with Cambio Cosmic has been initiated
  • Fredrik Hovbäck has been recruited as new CFO replacing Lars Höst, who leaves the company

Highlights post-period end

  • Ortivus and SCHILLER AG sign a distribution agreement covering the Nordic market
  • Mehrdad Rastju has been recruited as delivery manager and will become a part of the leadership team

April – June 2020

  • Net sales amounted to 40.2 (11.8) MSEK, which is an increase in sales of 242%
  • Operating profit cleared for comparative distortion items amounted to 6.9 (-2.0) MSEK. Operating profit, including comparative distortion items, amounted to 6.9 (-4.6) MSEK
  • EBITDA cleared for comparative distortion items, amounted to 7.6 (-0.5) MSEK. EBITDA including comparative distortion items, amounted to 7.6 (-3.0) MSEK
  • Profit after tax was 6.9 (-4.7) MSEK
  • Earnings per share after tax and before and after dilution amounted to 0.15 (-0.13) SEK

January – June 2020

  • Net sales amounted to 60.4 (23.3) MSEK, which is an increase in sales of 159%
  • Operating profit cleared for comparative distortion items, amounted to 8.0 (-5.1) MSEK. Operating profit including comparative distortion items, amounted to 8.0 (-10.4) MSEK
  • EBITDA cleared for comparative distortion items, amounted to 9.4 (-1.9) MSEK. EBITDA including comparative distortion items, amounted to 9.4 (-7.2) MSEK
  • Profit after tax was 7.9 (-10.7) MSEK
  • Earnings per share after tax and before and after dilution, amounted to 0.18 (-0.32) SEK
Amount in KSEK Apr-Jun 2020 Apr-Jun 2019 Jan-Jun 2020 Jan-Jun 2019 Jan-Dec 2019
Net sales 40 208 11 760 60 369 23 340 50 848
Gross margin, % 28% 44% 34% 41% 41%
Operating profit,
excl. comparative distortion items
6 883 -1 999 7 996 -5 137 -10 197
Operating margin, %
excl. comparative distortion items
17% -17% 13% -22% -20%
EBITDA,
excl. comparative distortion items
7 637 -463 9 412 -1 917 -3 271

Get in touch

Empower your team with smarter tools

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required